Pharma major Lupin reported a net profit of Rs 1,216 crore for the fiscal ended March 2021 against a loss of Rs 269 crore in the previous fiscal. However, total income fell 3.53% to Rs 15,299 crore in FY20-21 against Rs 15,858 crore in FY19-20.
Related Keywords
Sun Pharma , Nilesh Gupta , Cipla , Managing Director , Lupin Q4 Net Profit , Lupin Q4 Earnings , Lupin , Upin Total Income , Upin Fy20 Net Profit , சூரியன் பார்மா , நிலேஷ் குப்தா , சிப்லா , நிர்வகித்தல் இயக்குனர் ,
comparemela.com © 2020. All Rights Reserved.